脱毛症治療の世界市場(~2027)

• 英文タイトル:Alopecia Treatment Market Research Report by Disease Type, Sales Channel, Gender, Treatment Option, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Alopecia Treatment Market Research Report by Disease Type, Sales Channel, Gender, Treatment Option, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「脱毛症治療の世界市場(~2027)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2301H065
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、245ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の市場調査レポートでは、2021年の2,796.90百万ドルであった世界の脱毛症治療市場規模が、2022年には3,020.51百万ドルへ到達し、2027年までにCAGR 8.17%増加して4,480.88百万ドルへ成長すると見込まれています。本調査レポートでは、脱毛症治療の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患種類別(円形脱毛症、完全脱毛症、全身性脱毛症、男性型脱毛症、その他)分析、販売チャネル別(OTC、処方箋)分析、性別(女性、男性)分析、治療オプション別(アントラリン、コルチコステロイド、JAK阻害剤、メトトレキサート(MTX)、局所免疫療法)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報など、以下の構成でお届けいたします。なお、当レポートに記載されている会社情報にはAclaris Therapeutics, Inc.、BiologicsMD, Inc.、Cipla, Inc、Cirrus Hair Centers、Curallux, LLC、Daiichi Sankyo Inc.、Die Vita-Cos-Med Klett-Loch GmbH、Fagron NV、Follica, Inc.、Follicum AB、GlaxoSmithKline PLC、HCell Inc.、Johnson & Johnson Services, Inc.、Lexington Intl., LLC、Merck & Co., Inc.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概
・市場インサイト
・世界の脱毛症治療市場規模:疾患種類別
- 円形脱毛症における市場規模
- 完全脱毛症における市場規模
- 全身性脱毛症における市場規模
- 男性型脱毛症における市場規模
- その他疾患における市場規模
・世界の脱毛症治療市場規模:販売チャネル別
- OTCチャネルの市場規模
- 処方箋チャネルの市場規模
・世界の脱毛症治療市場規模:性別
- 女性における市場規模
- 男性における市場規模
・世界の脱毛症治療市場規模:治療オプション別
- アントラリンにおける市場規模
- コルチコステロイドにおける市場規模
- JAK阻害剤における市場規模
- メトトレキサート(MTX)における市場規模
- 局所免疫療法における市場規模
・世界の脱毛症治療市場規模:地域別
- 南北アメリカの脱毛症治療市場規模
アメリカの脱毛症治療市場規模
カナダの脱毛症治療市場規模
ブラジルの脱毛症治療市場規模
...
- アジア太平洋の脱毛症治療市場規模
日本の脱毛症治療市場規模
中国の脱毛症治療市場規模
インドの脱毛症治療市場規模
韓国の脱毛症治療市場規模
台湾の脱毛症治療市場規模
...
- ヨーロッパ/中東/アフリカの脱毛症治療市場規模
イギリスの脱毛症治療市場規模
ドイツの脱毛症治療市場規模
フランスの脱毛症治療市場規模
ロシアの脱毛症治療市場規模
...
- その他地域の脱毛症治療市場規模
・競争状況
・企業情報

The Global Alopecia Treatment Market size was estimated at USD 2,796.90 million in 2021 and expected to reach USD 3,020.51 million in 2022, and is projected to grow at a CAGR 8.17% to reach USD 4,480.88 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Alopecia Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Type, the market was studied across Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Cicatricial Alopecia, and Traction Alopecia.

Based on Sales Channel, the market was studied across OTC and Prescription.

Based on Gender, the market was studied across Female and Male.

Based on Treatment Option, the market was studied across Anthralin, Corticosteroid, JAK Inhibitors, Methotrexate, and Topical Immunotherapy.

Based on End User, the market was studied across Dermatology Clinics and Homecare Setting.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Alopecia Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Alopecia Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Alopecia Treatment Market, including Aclaris Therapeutics, Inc., BiologicsMD, Inc., Cipla, Inc, Cirrus Hair Centers, Curallux, LLC, Daiichi Sankyo Inc., Die Vita-Cos-Med Klett-Loch GmbH, Fagron NV, Follica, Inc., Follicum AB, GlaxoSmithKline PLC, HCell Inc., Johnson & Johnson Services, Inc., Lexington Intl., LLC, Merck & Co., Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd, and Transitions Hair Pty Ltd.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Alopecia Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Alopecia Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Alopecia Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Alopecia Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Alopecia Treatment Market?
6. What is the market share of the leading vendors in the Global Alopecia Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Alopecia Treatment Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
5.1.1.2. Unhealthy lifestyle including consumption of tobacco and alcohol
5.1.1.3. Increasing working population and escalating stress indices
5.1.1.4. Hereditary-pattern baldness being the most common cause
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies
5.1.3. Opportunities
5.1.3.1. Growing in disposable incomes and building emphasis on aesthetics
5.1.3.2. Rising in acceptance toward alopecia therapeutic options
5.1.3.3. Advancement in therapeutic solutions
5.1.4. Challenges
5.1.4.1. Side-effects related to some hair loss treatment therapies
5.2. Cumulative Impact of COVID-19

6. Alopecia Treatment Market, by Disease Type
6.1. Introduction
6.2. Alopecia Areata
6.3. Alopecia Totalis
6.4. Alopecia Universalis
6.5. Androgenetic Alopecia
6.6. Cicatricial Alopecia
6.7. Traction Alopecia

7. Alopecia Treatment Market, by Sales Channel
7.1. Introduction
7.2. OTC
7.3. Prescription

8. Alopecia Treatment Market, by Gender
8.1. Introduction
8.2. Female
8.3. Male

9. Alopecia Treatment Market, by Treatment Option
9.1. Introduction
9.2. Anthralin
9.3. Corticosteroid
9.4. JAK Inhibitors
9.5. Methotrexate
9.6. Topical Immunotherapy

10. Alopecia Treatment Market, by End User
10.1. Introduction
10.2. Dermatology Clinics
10.3. Homecare Setting

11. Americas Alopecia Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Alopecia Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Aclaris Therapeutics, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. BiologicsMD, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Cipla, Inc
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Cirrus Hair Centers
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Curallux, LLC
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Daiichi Sankyo Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Die Vita-Cos-Med Klett-Loch GmbH
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Fagron NV
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Follica, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Follicum AB
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. GlaxoSmithKline PLC
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. HCell Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Johnson & Johnson Services, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Lexington Intl., LLC
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Merck & Co., Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. RepliCel Life Sciences Inc.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Sun Pharmaceutical Industries Ltd
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Transitions Hair Pty Ltd
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing




• 英文レポート名:Alopecia Treatment Market Research Report by Disease Type, Sales Channel, Gender, Treatment Option, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
• 日本語訳:脱毛症治療の世界市場(~2027)
• レポートコード:MRC2301H065お問い合わせ(見積依頼・ご注文・質問)